iShares BIC 50

ETF description

The iShares BIC 50 ETF is designed to provide investors with targeted exposure to a diversified portfolio of 50 large‑cap companies that are selected based on a blend of best‑in‑class criteria. By tracking the BIC 50 index, this ETF focuses on high‑quality, leading companies with strong market positions and robust financial performance, aiming to deliver potential growth and stability.

Issuer details

iShares ETFs are issued and managed by BlackRock, the world’s largest asset management company.

With 800+ products globally and over $2trn in assets (as at June 2024), iShares ETFs are a flexible, low‑cost way for investors to gain exposure to various market segments, including fixed income, emerging markets and broad‑based indexes.

Index details

The BIC 50 index offers targeted exposure to 50 leading biotechnology companies, capturing the performance and innovation within the biotech sector. By focusing on firms with significant market influence and growth potential, the index provides investors with a concentrated view of the biotechnology industry. It serves as a benchmark for evaluating sector performance and a tool for investors interested in the advancements and opportunities within biotechnology.